Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

The Journal of Pediatrics

Volumn 102, Issue 6, 1983, Pages 895-906

  Gersony, Welton M ^a   Peckham, George J ^a   Ellison, R Curtis ^a   Miettinen, Olli S ^a   Nadas, Alexander S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PLACEBO;

BLEEDING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG THERAPY; EPIDEMIOLOGY; GREAT BLOOD VESSEL; HEART; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; PREMATURITY; THERAPY;

CLINICAL TRIALS; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; PLACEBOS; RANDOM ALLOCATION;

EID: 0020639454     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(83)80022-5     Document Type: Article

References (40)

1. Delayed closure of the ductus arteriosus in premature infants
2. Delayed closure of the ductus arteriosus
3. Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants
4. Patent ductus, prematurity and pulmonary disease
5. Persistent ductus arteriosus complicating the respiratory distress syndrome
6. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus
7. Patent ductus arteriosus in premature infants: Incidence, relation to pulmonary disease and management
8. Ligation of the patent ductus arteriosus in premature infants: Report of 45 cases
9. Management of premature infants with patent ductus arteriosus
10. Ligation of patent ductus arteriosus for persistent respiratory distress syndrome in premature infants
11. Surgical closure of patent ductus arteriosus in the premature infant with respiratory distress
12. Improving the results of ligation of patent ductus arteriosus in small preterm infants
13. The ductus debate: Ligation in prematurity
14. Pharmacologic closure of patent ductus arteriosus in the premature infant
15. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis
16. Ductal manipulation: A note of caution
17. Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome
18. Age-dependent closure of the patent ductus arteriosus by indomethacin
19. Closure of the patent ductus arteriosus with ligation and indomethacin A consecutive experience
20. Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams
21. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus
22. Patent ductus arteriosus in infants of low birth weight
23. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants
24. Patent ductus arteriosus treated with ligation or indomethacin: A follow-up study
25. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants
26. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus: A double-blind controlled study
27. The disposition of indomethacin in preterm babies
28. The contribution of PDA in the neonate with severe RDS
29. Pharmacokinetics of indomethacin in the neonate: Relation of plasma indomethacin levels to response of the ductus arteriosus
30. Early closure of the patent ductus arteriosus in very low birth weight infants: A controlled trial
31. Indomethacin treatment for symptomatic patent ductus arteriosus: A double-blind control study
32. Prophylactic indomethacin therapy for patent ductus arteriosus in very low-birthweight infants
33. Pharmacokinetics of intravenously administered indomethacin in premature infants
34. Gestational age and indomethacin elimination in the neonate
35. Indomethacin disposition and indomethacin induced platelet dysfunction in premature infants
36. Indomethacin and its effect on renal function and urinary kallakrein excretion in premature infants with patent ductus arteriosus
37. Retrolental fibroplasia: Efficacy of vitamin E in a double-blind clinical study of preterm infants
38. Retrolental fibroplasia: Evidence for a role of the prostaglandin cascade in the pathogenesis of oxygen induced retinopathy in the newborn beagle
39. Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants